CanPrev Women's Probiotic Supplement - with Cranberry | 30 Caps
Visit the CanPrev Store| Brand | CanPrev |
| Serving | 1 capsule per day |
| Licensed Natural Health Product | NPN 80111463 |
| Quality Standards | Made in Canada |
| Country | Made in Canada  |
About this item
- NURTURE VAGINAL HEALTH: Formulated to help restore and maintain healthy vaginal flora, with targeted Lactobacillus strains to support a favourable microbial balance - not just a general digestive probiotic.
- CRANBERRY UTI SUPPORT: Each capsule adds 200 mg of concentrated cranberry (Vaccinium macrocarpon) extract, traditionally used in Herbal Medicine to help prevent recurrent urinary tract infections in women.
- TWO REAL, DOSED PROBIOTIC STRAINS: Lactobacillus acidophilus La-14 (8 billion CFU) and Lacticaseibacillus rhamnosus HN001 (2 billion CFU) - both strains and doses are printed on the label, for a total of 10 billion CFU per capsule.
- SHELF-STABLE CONVENIENCE: No refrigeration required - the formula is designed to maintain reliable potency at room temperature, so it travels easily in a bag or purse.
- SIMPLE ONCE-DAILY CAPSULE: Take 1 capsule per day, at least 2 to 3 hours before or after antibiotics. Use for at least 4 weeks to see beneficial effects.
- FREE FROM COMMON ALLERGENS: Gluten-free, dairy-free and soy-free, with no artificial colours, flavours or preservatives.
- CANADIAN, NPN-LICENSED QUALITY: Formulated and made in Canada by CanPrev. Licensed Natural Health Product, NPN 80111463.
Product Description
V-Biotik Vaginal & UTI - 10 Billion CFU, 2 Real Strains + Cranberry
CanPrev V-Biotik Vaginal & UTI is a source of probiotics formulated to help restore and maintain healthy vaginal flora, with 200 mg of cranberry (Vaccinium macrocarpon) extract to help prevent recurrent urinary tract infections. Each shelf-stable, once-daily vegetable capsule delivers 10 billion CFU from two real, dosed strains - Lactobacillus acidophilus La-14 and Lacticaseibacillus rhamnosus HN001. Licensed Natural Health Product, NPN 80111463. Licensed Natural Health Product NPN 80111463.
CanPrev V-Biotik Vaginal & UTI est une source de probiotiques formulée pour aider à rétablir et à maintenir une flore vaginale en santé, avec 200 mg d'extrait de canneberge (Vaccinium macrocarpon) pour aider à prévenir les infections urinaires récurrentes. Chaque capsule végétale, à prendre une fois par jour et stable à température ambiante, fournit 10 milliards d'UFC provenant de deux souches réelles et dosées - Lactobacillus acidophilus La-14 et Lacticaseibacillus rhamnosus HN001. Produit de santé naturel homologué, NPN 80111463.
2 Real, Dosed Strains Plus Cranberry - Not a Generic Blend
10 Billion CFU Minimum · Shelf-Stable · No Refrigeration Needed
10 Billion CFU From 2 Distinct, Dosed Strains
Lactobacillus acidophilus La-14 (8 billion CFU) and Lacticaseibacillus rhamnosus HN001 (2 billion CFU) - both the strains and their individual CFU counts are printed on the label.
Plus 200mg Cranberry for Urinary Support
A concentrated 50:1 cranberry (Vaccinium macrocarpon) extract, traditionally used in Herbal Medicine to help prevent recurrent urinary tract infections in women.
Advanced Ingredients, Superior Results
CanPrev V-Biotik Vaginal & UTI is a source of probiotics formulated to help restore and maintain healthy vaginal flora, with 200 mg of cranberry (Vaccinium macrocarpon) extract to help prevent recurrent urinary tract infections. Each shelf-stable, once-daily vegetable capsule delivers 10 billion CFU from two real, dosed strains - Lactobacillus acidophilus La-14 and Lacticaseibacillus rhamnosus HN001. Licensed Natural Health Product, NPN 80111463.
Lactobacillus acidophilus (La-14)
A Lactobacillus acidophilus strain studied in vitro and in animal models for antimicrobial activity against common vaginal pathogens and for modulating vaginal epithelial immune responses.
8 billion CFULacticaseibacillus rhamnosus (HN001)
A well-studied Lactobacillus strain examined, alone and in combination formulas, for vaginal microbiota support and gut-vaginal axis research.
2 billion CFU
Cranberry (Vaccinium macrocarpon) fruit extract, 50:1
A concentrated cranberry extract traditionally used in Herbal Medicine to help prevent recurrent urinary tract infections in women.
200 mg (equiv. 10,000 mg dried fruit)CanPrev Women's Probiotic: Supplement Facts
Product Facts
- Lactobacillus acidophilus La-148 billion CFU
- Lacticaseibacillus rhamnosus HN0012 billion CFU
- Cranberry extract Vaccinium macrocarpon fruit, 50:1 (DHE 10,000mg)200 mg
Non-Medicinal Ingredients: Non-medicinal ingredients: Vegetable-grade magnesium stearate, monopotassium phosphate, dipotassium phosphate, sodium chloride, sucrose, trehalose, ascorbic acid, acacia (Fibregum), vegetable capsule.
Recommended Use or Purpose: A source of probiotics to help support vaginal health. Helps restore and maintain healthy vaginal flora. Cranberry helps prevent urinary tract infections (UTIs). Authorized under Natural Health Product licence NPN 80111463.
Recommended Dose (Adults): Take 1 capsule per day, at least 2 to 3 hours before or after antibiotics, or as directed by a health care practitioner. Duration of Use: Use for at least 4 weeks to see beneficial effects. No refrigeration required - store in a cool, dry place.
Cautions and Warnings: As with any natural health product, you should consult a health care practitioner prior to use especially if you have a fever, vomiting, bloody diarrhea or severe abdominal pain. Stop use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persist beyond 3 days. Do not use if seal is broken. Keep out of reach of children. Contraindications: Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
Actual product packaging and materials may contain more and different information than shown on our website. Always read labels, warnings and directions before using or consuming a product. This item is sold and shipped by Amazon.ca; purchases are completed on Amazon.
Info-produit
- Lactobacillus acidophilus La-148 billion CFU
- Lacticaseibacillus rhamnosus HN0012 billion CFU
- Extrait de canneberge Vaccinium macrocarpon fruit, 50:1 (EPD 10 000mg)200 mg
Ingrédients non médicinaux : Ingrédients non médicinaux : Stéarate de magnésium de grade végétal, phosphate de monopotassium, phosphate de dipotassium, chlorure de sodium, sucrose, tréhalose, acide ascorbique, acacia (Fibregum), capsule végétale.
Usage ou fins recommandés : Une source de probiotiques pour aider à soutenir la santé vaginale. Aide à rétablir et à maintenir une flore vaginale en santé. La canneberge aide à prévenir les infections des voies urinaires. Autorisé sous la licence de produit de santé naturel NPN 80111463.
Dose recommandée (adultes) : Prendre 1 capsule par jour, au moins 2 à 3 heures avant ou après la prise d'antibiotiques, ou selon les directives d'un praticien de soins de santé. Durée d'utilisation : Utiliser pendant au moins 4 semaines afin de constater des effets bénéfiques. Aucune réfrigération requise - conserver dans un endroit frais et sec.
Mises en garde et avertissements : Comme pour tout produit de santé naturel, vous devriez consulter un praticien de soins de santé avant l'usage, surtout si vous souffrez de fièvre, de vomissements, de diarrhée sanglante ou de douleurs abdominales intenses. Cessez l'utilisation et consultez un praticien de soins de santé si des symptômes de troubles digestifs (par ex., diarrhée) se manifestent, s'aggravent et/ou persistent au-delà de 3 jours. Ne pas utiliser si le sceau de sécurité est brisé. Tenir hors de la portée des enfants. Contre-indications : Ne pas utiliser ce produit si vous souffrez d'un déficit immunitaire (par ex., sida, lymphome, patients subissant un traitement prolongé aux corticostéroïdes).
NPN 80111463
Support vaginal flora and urinary wellness with a targeted daily probiotic
Get CanPrev V-Biotik Vaginal & UTI (Women's Probiotic) on Amazon.ca - fast, protected delivery.
Get it on Amazon.caWhy CanPrev V-Biotik Vaginal & UTI
A targeted women's probiotic - two real, dosed Lactobacillus strains plus cranberry - built for vaginal flora and urinary wellness, not just general digestion.
10 Billion CFU, 2 Real Strains
Lactobacillus acidophilus La-14 (8 billion CFU) and Lacticaseibacillus rhamnosus HN001 (2 billion CFU) - both strains and their exact CFU counts are printed on the label.
Plus 200mg Cranberry Extract
A concentrated 50:1 cranberry (Vaccinium macrocarpon) extract, traditionally used in Herbal Medicine to help prevent recurrent urinary tract infections in women.
Shelf-Stable - No Refrigeration Needed
Formulated to remain potent at room temperature, so it is easy to keep on a counter, in a bag, or while travelling.
Made in Canada, NPN Licensed
Formulated and made in Canada by CanPrev. Licensed Natural Health Product, NPN 80111463.
Inside every capsule
10 billion CFU from two real, dosed probiotic strains - Lactobacillus acidophilus La-14 and Lacticaseibacillus rhamnosus HN001 - plus 200 mg of concentrated cranberry (Vaccinium macrocarpon) extract, in a shelf-stable, once-daily vegetable capsule.
How to use it
Take 1 capsule daily
Adults take one (1) capsule per day, or as directed by a health care practitioner.
Space it from antibiotics
If you are taking antibiotics, take this product at least 2 to 3 hours before or after your dose.
Give it at least 4 weeks
Use for at least 4 weeks to see beneficial effects on vaginal flora and urinary wellness.
Know the cautions
Consult a health care practitioner before use if you have a fever, vomiting, bloody diarrhea or severe abdominal pain. Do not use if you have an immune-compromised condition.
What the research says about the key ingredients
Educational summaries of published research on the individual strains and cranberry in this formula - Lactobacillus acidophilus La-14, Lacticaseibacillus rhamnosus HN001, and Vaccinium macrocarpon (cranberry) - shared for education, not as claims about this finished product. V-Biotik Vaginal & UTI's own authorized claims are the statements made under its Natural Health Product licence, NPN 80111463.
Oral intake did not detect vaginal colonization in a healthy-women RCT
A randomised, placebo-controlled trial in 50 women with healthy vaginal microbiota found that 2 weeks of oral La-14 and HN001 did not produce detectable vaginal colonization above the assay's detection limit; vaginal microbiota and pH remained stable and optimal throughout, and no safety concerns were raised.
Human RCT (null colonization result)Attenuated Gardnerella vaginalis-induced vaginosis in mice
In a mouse model of bacterial vaginosis induced by Gardnerella vaginalis, oral or intravaginal administration of HN001 and La-14 significantly reduced epithelial disruption and inflammatory markers, with La-14 the most effective of the two strains tested.
Animal studyInhibited a toxin-producing Staphylococcus aureus strain in vitro
Laboratory testing found HN001 inhibited production of toxic shock syndrome toxin-1 by Staphylococcus aureus (partly via acidification), while La-14 was directly bactericidal against the same organism; neither strain triggered inflammatory signaling from human vaginal epithelial cells on its own.
In vitro studyFewer recurrences of vulvovaginal candidiasis as an antifungal adjunct
In women with recurrent vulvovaginal candidiasis, an oral formula combining a similarly-designated Lactobacillus acidophilus strain (GLA-14), HN001 and bovine lactoferrin - lactoferrin is not part of this product - as an adjunct to clotrimazole cut six-month recurrence to 29% versus 100% with placebo.
Human RCTImproved Nugent score and fewer bacterial vaginosis recurrences
As an adjunct to metronidazole for recurrent bacterial vaginosis, the same GLA-14 + HN001 + lactoferrin combination - again, lactoferrin is not in this product - significantly improved Nugent score, symptoms and six-month recurrence versus placebo.
Human RCTConfirmed the two species can reach the vagina after oral dosing
In women with intermediate vaginal microbiota, oral intake of a Lactobacillus acidophilus GLA-14 and Lactobacillus rhamnosus HN001 mixture (with lactoferrin) led to detectable vaginal colonization by both strains, correlating with Nugent score normalization and symptom improvement.
Human RCTInhibited bacterial vaginosis and aerobic vaginitis pathogens in vitro
Co-culture testing found HN001 and GLA-14 (a similarly-designated Lactobacillus acidophilus strain used in a different manufacturer's blend) showed antimicrobial activity against Gardnerella vaginalis, Atopobium vaginae, Staphylococcus aureus and E. coli - the organisms most implicated in bacterial vaginosis and aerobic vaginitis.
In vitro studyReduced potential vaginal pathobionts in pregnant women
In overweight/obese pregnant women, a probiotic containing HN001 (alongside a Bifidobacterium strain) was associated with a lower abundance of potential vaginal pathobionts such as Ureaplasma and Prevotella species compared with placebo.
Human RCTA large trial designed to test HN001 against bacterial vaginosis in pregnancy
The Probiotics in Pregnancy (PiP) Study protocol describes a 400-woman, double-blind RCT testing whether HN001 taken from early pregnancy through breastfeeding reduces maternal bacterial vaginosis, Group B Streptococcus colonization and gestational diabetes, alongside infant eczema outcomes - a study design/rationale paper, not yet reporting final results here.
Study protocolCut culture-confirmed UTIs by roughly half in women with a history of recurrence
A 6-month, multicenter, placebo-controlled trial in 150 women with a history of recurrent UTI found a daily whole cranberry powder capsule reduced culture-confirmed UTI risk by 52% and delayed time to first UTI episode, with no safety concerns.
Human RCTReduced UTI recurrence and E. coli colonization over 12 months
In 160 women with recurrent uncomplicated cystitis, daily high-dose cranberry proanthocyanidins significantly lowered the number of UTIs and reduced E. coli detected in both vaginal and rectal swabs versus placebo over a 12-month period.
Human RCTReduced UTI episodes in diabetic postmenopausal women on SGLT-2 inhibitors
In postmenopausal women with type 2 diabetes taking SGLT-2 inhibitor medication (a drug class linked to elevated UTI risk), six months of standardized cranberry extract supplementation kept UTI-episode counts steady while the placebo group's episodes rose.
Human RCTNetwork meta-analysis: cranberry juice and tablets lower UTI and antibiotic use
A network meta-analysis of 20 trials (3091 participants) found cranberry juice was associated with a 54% lower UTI rate than no treatment and a 49% lower rate of antibiotic use than placebo liquid, with cranberry tablets showing smaller but still positive effects.
Meta-analysisOne of several non-antibiotic options shown effective across 50 trials
A network meta-analysis of 50 RCTs (10,495 subjects) found cranberry (risk ratio 0.72), along with D-mannose, probiotics and a UTI vaccine, significantly reduced UTI incidence versus placebo, with no significant difference in adverse events between interventions.
Meta-analysisNo trials found assessing cranberry as a treatment for an active UTI
A Cochrane review specifically searching for trials of cranberry products to treat (not prevent) existing urinary tract infections found no randomized controlled trials meeting its criteria - an important distinction, since cranberry's evidence base is about prevention, not treating an active infection.
Cochrane systematic review (null result)Proanthocyanidins block E. coli from adhering to the urinary tract
A review of cranberry-derived bioactives found that A-type proanthocyanidins are the primary compounds responsible for preventing uropathogenic E. coli from adhering to urothelial cells, with gut-microbiota metabolism of these compounds further enhancing the effect.
ReviewPolyphenol mechanism reviewed alongside combined probiotic-cranberry approaches
A review of cranberry polyphenols concluded their anti-adhesive activity against uropathogenic E. coli is the leading mechanism behind UTI-prevention benefits, and noted growing research interest in combining cranberry with probiotics as a complementary, non-antibiotic strategy.
ReviewBest evidence supports prevention, with honest caveats on cost-effectiveness
A review of cranberry's clinical evidence concluded it can help prevent UTI recurrence, but noted it shows lower effectiveness in higher-risk populations and that cost-effectiveness has been questioned - an honest limitation, not a reason to expect it will resolve every case.
ReviewNo liver toxicity signal in a systemic-safety animal study
In rats given systemic Lactobacillus acidophilus La-14 or a related L. rhamnosus strain daily for 30 days, no hepatic histopathological alterations (inflammation, necrosis or fibrosis) were observed in either probiotic group compared to control.
Animal study (safety)A multispecies blend including HN001 and La-14 reversed stress-related gut changes in mice
In a mouse model of preconceptional stress, a multispecies probiotic containing Lactobacillus rhamnosus HN001, L. acidophilus La-14 and Bifidobacterium lactis HN019 reversed stress-induced anxiety-like behavior and restored gut microbial diversity in mothers, without any reported adverse effects.
Animal studyLa-14 studied as a respiratory immune modulator in mice
In a mouse model, oral La-14 supplementation was associated with increased lymphocyte infiltration in lung tissue, suggesting a stimulatory effect on the respiratory immune system - illustrating this strain's broader immune-modulating research beyond the vaginal indication used here.
Animal studyLong-term Lactobacillus/Bifidobacterium use has a good pediatric safety record
A systematic review of 14 pediatric RCTs on Lactobacillus and Bifidobacterium strains for respiratory infection prevention found a modest protective effect and, across all included trials, a good long-term safety profile with no serious adverse events attributed to the probiotic strains.
Systematic reviewCranberry plus antibiotics performed well in children with recurrent UTI
A systematic review and meta-analysis of prophylaxis options in children with recurrent UTIs found cranberry products, alongside nitrofurantoin, reduced the odds of symptomatic UTI recurrence compared to control - evidence in a different (pediatric) population, shared here for the ingredient's broader research base.
Systematic reviewNo adverse shift in the urinary microbiome from cranberry or vitamin C
A pilot RCT in 27 healthy women found neither cranberry nor ascorbic acid supplementation produced significant shifts in the genitourinary microbiome versus control over the study period, with no safety concerns raised - a reassuring null finding on tolerability.
Human RCT (null result)Frequently asked questions
What is CanPrev V-Biotik Vaginal & UTI (Women's Probiotic)?
It's a probiotic capsule formulated for women, delivering 10 billion CFU from two real, dosed strains - Lactobacillus acidophilus La-14 and Lacticaseibacillus rhamnosus HN001 - plus 200 mg of cranberry (Vaccinium macrocarpon) extract. It's a source of probiotics that helps restore and maintain healthy vaginal flora, and cranberry helps prevent urinary tract infections (UTIs).
How is this different from a general digestive probiotic?
This formula is specifically built around two Lactobacillus strains researched for vaginal and urogenital health, combined with cranberry for urinary support - rather than a broad multi-strain blend aimed at general gut health.
Do I need to refrigerate it?
No. It's formulated to be shelf-stable at room temperature - keep it in a cool, dry place, out of direct sunlight.
How do I take it, and how long before I notice a difference?
Take 1 capsule per day, at least 2 to 3 hours before or after antibiotics if you're taking them. Use for at least 4 weeks to see beneficial effects.
Is it free of common allergens?
Yes - it's formulated without gluten, dairy or soy, in a vegetable capsule, with no artificial colours, flavours or preservatives.
Who should not use it?
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment). Consult a health care practitioner prior to use especially if you have a fever, vomiting, bloody diarrhea or severe abdominal pain, and stop use if digestive upset persists beyond 3 days.
What size does it come in?
It comes in one size: 30 vegetable capsules, a 30-day supply at 1 capsule per day.
Where do I buy it?
Use the orange button on this page - it takes you to the CanPrev listing on Amazon.ca for secure checkout and fast delivery.
Support vaginal flora and urinary wellness with a targeted daily probiotic
Get CanPrev V-Biotik Vaginal & UTI (Women's Probiotic) on Amazon.ca - fast, protected delivery.
Get it on Amazon.caNatural Health Product NPN 80111463. Helps restore and maintain healthy vaginal flora. Cranberry helps prevent urinary tract infections (UTIs). Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment). Consult a health care practitioner prior to use especially if you have a fever, vomiting, bloody diarrhea or severe abdominal pain. Results may vary.
Important information
Safety Information
Cautions and Warnings: As with any natural health product, you should consult a health care practitioner prior to use especially if you have a fever, vomiting, bloody diarrhea or severe abdominal pain. Stop use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persist beyond 3 days. Do not use if seal is broken. Keep out of reach of children. Contraindications: Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
Indications
Recommended Use or Purpose: A source of probiotics to help support vaginal health. Helps restore and maintain healthy vaginal flora. Cranberry helps prevent urinary tract infections (UTIs). Authorized under Natural Health Product licence NPN 80111463.
Ingredients
Medicinal ingredients (per capsule): Lactobacillus acidophilus La-14 8 billion CFU; Lacticaseibacillus rhamnosus HN001 2 billion CFU; Cranberry extract (Vaccinium macrocarpon) fruit, 50:1 (DHE 10,000mg) 200mg. Total: 10 billion CFU plus 200mg cranberry extract. Non-medicinal ingredients: Vegetable-grade magnesium stearate, monopotassium phosphate, dipotassium phosphate, sodium chloride, sucrose, trehalose, ascorbic acid, acacia (Fibregum), vegetable capsule. NMIs are subject to change - always read and follow the label.
Directions
Recommended Dose (Adults): Take 1 capsule per day, at least 2 to 3 hours before or after antibiotics, or as directed by a health care practitioner. Duration of Use: Use for at least 4 weeks to see beneficial effects. No refrigeration required - store in a cool, dry place.
Legal Disclaimer
Actual product packaging and materials may contain more and different information than shown on our website. Always read labels, warnings and directions before using or consuming a product. This item is sold and shipped by Amazon.ca; purchases are completed on Amazon.